FRANCISCO JAVIER
GIL BEA
Instituto de Investigación Sanitaria de Navarra
Pamplona, EspañaPublications in collaboration with researchers from Instituto de Investigación Sanitaria de Navarra (4)
2022
-
Genetic Inactivation of Free Fatty Acid Receptor 3 Impedes Behavioral Deficits and Pathological Hallmarks in the APPswe Alzheimer’s Disease Mouse Model
International Journal of Molecular Sciences, Vol. 23, Núm. 7
2021
-
Corticosteroid-binding-globulin (CBG)deficient mice show high pY216-GSK3β and phosphorylated-Tau levels in the hippocampus
PLoS ONE, Vol. 16, Núm. 2 February
2018
-
Increased Levels of Brain Adrenomedullin in the Neuropathology of Alzheimer’s Disease
Molecular Neurobiology, Vol. 55, Núm. 6, pp. 5177-5183
2016
-
Down-regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease
Hippocampus, Vol. 26, Núm. 10, pp. 1303-1312